Erbitux and dysphagia Patient Reports February 09, 2010

Erbitux Side Effects Report #4614793-1
Erbitux side effect was reported by a Health Professional from on Feb 28, 2005. Male patient, 75 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia. Erbitux dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DIPHENHYDRAMINE, DURAGESIC PATCH, PERCOCET, TAXOL. Patient died on 02/27/2005.

Erbitux Side Effects Report #5473430-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2007. Female patient, 56 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, erythema, lip swelling, pruritus, tongue disorder. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5213230-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 212.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dehydration, dysphagia, mucosal inflammation, vomiting. Erbitux dosage: 250 MG/M2 ONCE/WEEK IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5213286-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 212.1 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dehydration, dysphagia, mucosal inflammation, pain , vomiting. Erbitux dosage: 250 MG/M2 ONCE / WEEK IV DRIP. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5217018-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, mucosal inflammation, oxygen saturation decreased, pneumonia aspiration, vomiting. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5234323-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, infection , mucosal inflammation, pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5235530-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, infection , mucosal inflammation, pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5242590-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 13, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, infection , mucosal inflammation, nausea , pneumonia aspiration, saliva altered. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5256642-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dehydration, dysphagia, infection , mucosal inflammation, nausea , pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5267246-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 51 years of age, weighting 211.6 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: catheter related infection, cough, dehydration, dysphagia, mucosal inflammation, nausea , pneumonia aspiration. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5405814-7
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2007. Female patient, 50 years of age, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, erythema, lip swelling, pruritus, tongue disorder. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, DECADRON. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5268255-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with tonsil cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, weight decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, FENTANYL, OXYCODONE, GABAPENTIN, DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5502760-5
Erbitux side effect was reported by a Health Professional from GERMANY on Oct 23, 2007. Female patient, 81 years of age, was diagnosed with squamous cell carcinoma, dysphagia and was treated with Erbitux. After drug was administered, patient experienced the following side effects: cough, dysphagia, wheezing. Erbitux dosage: unknown. During the same period patient was treated with MAGNESIUM SULPHATE, LANSOPRAZOLE. Patient recovered.

Erbitux Side Effects Report #4978093-2
Erbitux side effect was reported by a Consumer or non-health professional from GERMANY on Apr 11, 2006. Male patient, 58 years of age, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5411398-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2007. Male patient, 54 years of age, weighting 194.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dry mouth, dysphagia. Erbitux dosage: unknown. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5578344-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2007. Male patient, 45 years of age, weighting 103.6 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dehydration, dizziness , dysphagia, hyperuricaemia, hypocalcaemia, hypokalaemia, hypotension. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5682440-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2008. Male patient, weighting 158.7 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, granulocyte count decreased, hyponatraemia, lymphopenia, radiation skin injury, stomatitis, white blood cell count decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, AVELOX, CIPRO, VANCOMYCIN, LACTULOSE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5692316-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2008. Male patient, weighting 158.7 lb, was diagnosed with squamous cell carcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, granulocyte count decreased, hyponatraemia, lymphopenia, radiation skin injury, stomatitis, white blood cell count decreased. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, AVELOX, CIPRO, VANCOMYCIN, LACTULOSE, NEUPOGEN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5091753-0
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2006. Male patient, 73 years of age, weighting 169.8 lb, was diagnosed with rectal cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, rash . Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.


Erbitux Side Effects Report #6083619-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2009. Male patient, 77 years of age, weighting 130.1 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, fatigue, nausea . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6086140-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2009. Male patient, 77 years of age, weighting 130.1 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, fatigue, nausea . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5384439-6
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5395052-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 20, 2007. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA, FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5040855-3
Erbitux side effect was reported by a Physician from UNITED STATES on June 27, 2006. Female patient, 74 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5064420-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 27, 2006. Female patient, 74 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, CISPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5449856-4
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2007. Male patient, 69 years of age, weighting 180.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, ill-defined disorder, infusion related reaction, memory impairment, no therapeutic response, oesophageal disorder, oral intake reduced. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #5684812-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 69 years of age, weighting 180.8 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, gastrointestinal oedema, no therapeutic response, skin infection. Erbitux dosage: unknown. During the same period patient was treated with NEUPOGEN, ZOFRAN, BENADRYL, TYLENOL. Patient recovered.

Erbitux Side Effects Report #5489879-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2007. Male patient, 59 years of age, weighting 172.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, pain . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOL, DECADRON, TYLENOL W, CIPRO. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5091843-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 11, 2006. Female patient, 57 years of age, weighting 165.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acne , chills, dehydration, dysphagia, febrile neutropenia, metastasis, mucosal inflammation, pain , pyrexia. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA, DIOVAN, HYDROCHLOROTHIAZIDE, NORMODYNE, LEXAPRO, PREVACID, MINOCYCLINE, FIORICET. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5036924-4
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 21, 2006. Female patient, 56 years of age, weighting 121.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5082039-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Aug 04, 2006. Female patient, 52 years of age, weighting 154.3 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: acne , cystitis, dysphagia, mucosal inflammation, neutropenia. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5566478-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, 49 years of age, weighting 156.5 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, ROXICET, COLACE, SENNA, MAGNESIUM OXIDE, MINOCYCLINE, LIDOCAINE VISCOUS. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5627956-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Male patient, 47 years of age, weighting 138.9 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, constipation , dysphagia, nausea . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5260954-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Male patient, 39 years of age, weighting 160.9 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5062761-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 24, 2006. Female patient, weighting 157.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, febrile neutropenia, mucosal inflammation. Erbitux dosage: 493 MG IV/EVERY WEEK. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5068135-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 21, 2006. Female patient, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5167860-0
Erbitux side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2006. Male patient, weighting 150.4 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, nausea , stomatitis. Erbitux dosage: 458 MG IV / WEEKLY. During the same period patient was treated with CISPLATIN. Patient recovered.

Erbitux Side Effects Report #5017496-7
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, weighting 126.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, fatigue. Erbitux dosage: 430 MG/WEEK IV. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5017497-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, weighting 126.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, stomatitis. Erbitux dosage: 430 MG/WEEK IV. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5026532-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on June 13, 2006. Male patient, weighting 116.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, fatigue. Erbitux dosage: unknown. During the same period patient was treated with ALIMTA. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5038874-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, weighting 145.0 lb, was diagnosed with neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, oral intake reduced. Erbitux dosage: 363 MG IV. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5581982-1
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with nasopharyngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, stomatitis. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN, ZOFRAN, TEGRETOL, CITALOPRAM HYDROBROMIDE, SENNA, ZANTAC, ATIVAN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5110085-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2006. Female patient, 51 years of age, weighting 101.4 lb, was diagnosed with nasopharyngeal cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: asthenia, dysphagia, erythema, fatigue, febrile neutropenia, leukopenia, migraine , mucosal inflammation, pharyngolaryngeal pain. Erbitux dosage: 250 MG ONCE/WEEK IV DRIP. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5052798-X
Erbitux side effect was reported by a Health Professional from UNITED STATES on July 13, 2006. Female patient, 77 years of age, weighting 172.0 lb, was diagnosed with lung neoplasm malignant and was treated with Erbitux. After drug was administered, patient experienced the following side effects: carotid artery disease , cerebral atrophy, cerebral ischaemia, cerebrovascular accident, dysphagia, ejection fraction decreased, embolic cerebral infarction, transient ischaemic attack. Erbitux dosage: 458 MG WEKLY X 4 IV DRIP. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5105664-5
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, 65 years of age, weighting 136.7 lb, was diagnosed with lung cancer metastatic and was treated with Erbitux. After drug was administered, patient experienced the following side effects: diarrhoea, dyspepsia, dysphagia, gastrooesophageal reflux disease, glossitis, glossodynia, mucosal inflammation, oesophageal candidiasis, oesophageal pain. Erbitux dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6086551-5
Erbitux side effect was reported by a Physician from GERMANY on Feb 13, 2009. Male patient, 71 years of age, weighting 174.2 lb, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, dysphagia. Erbitux dosage: LOADING DOSE:400MG/M2,ONCE;26AUG08-UNK,AUG-08 TO 17-SEP-08 (1 MONTHS),A TOTAL OF 5 INF. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6103083-6
Erbitux side effect was reported by a Physician from GERMANY on Feb 25, 2009. Male patient, 71 years of age, weighting 174.2 lb, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dermatitis acneiform, dysphagia. Erbitux dosage: LOADING DOSE:400MG/M2,ONCE;26AUG08-UNK,AUG-08 TO 17-SEP-08 (1 MONTHS),A TOTAL OF 5 INF. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6045028-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Jan 14, 2009. Male patient, 65 years of age, weighting 114.6 lb, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dehydration, dysphagia, lymphopenia, nausea , oesophageal pain. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6028191-X
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2008. Male patient, 59 years of age, weighting 178.6 lb, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: apnoea, bradycardia, dehydration, dysphagia, hypotension, odynophagia, pyrexia, stomatitis. Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.


Erbitux Side Effects Report #5913245-6
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2008. Male patient, 49 years of age, weighting 141.1 lb, was diagnosed with head and neck cancer  and was treated with Erbitux. After drug was administered, patient experienced the following side effects: anorexia, dehydration, dysphagia, fatigue, nausea , oesophagitis, sepsis . Erbitux dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4592987-1
Erbitux side effect was reported by a Health Professional from on Dec 01, 2004. Male patient, 56 years of age, weighting 205.0 lb, was diagnosed with colon cancer stage iii and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, flushing. Erbitux dosage: 808 MG X 1, D/C AFTER 15 MINUTES. During the same period patient was treated with ZOFRAN, BENADRYL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #4840501-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2005. Female patient, 57 years of age, weighting 178.6 lb, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, dysphonia, dyspnoea, increased upper airway secretion. Erbitux dosage: unknown. During the same period patient was treated with IRINOTECAN, ALOXI, DECADRON, COZAAR, ITRACONAZOLE. Patient recovered.

Erbitux Side Effects Report #5684538-5
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Male patient, 45 years of age, was diagnosed with colon cancer and was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea. Erbitux dosage: unknown. During the same period patient was treated with BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6131495-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Oct 06, 2008. Male patient, 72 years of age, was treated with Erbitux. After drug was administered, patient experienced the following side effects: chapped lips, dysphagia, hypoaesthesia, lip haemorrhage, lip swelling. Erbitux dosage: unknown. During the same period patient was treated with VICODIN, SALAGEN. Patient recovered.

Erbitux Side Effects Report #5684821-3
Erbitux side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2007. Male patient, 69 years of age, weighting 165.3 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dry skin, dysphagia. Erbitux dosage: unknown. Patient recovered.

Erbitux Side Effects Report #5449572-9
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Male patient, 48 years of age, weighting 118.0 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dyspepsia, dysphagia, fatigue, pain . Erbitux dosage: 250MG/M2, IV, WKLY. During the same period patient was treated with FENTANYL, ZOLPIDEM TARTRATE, PHENYTOIN, ESOMPRAZOLE, LABETOL, AMLODOPINE, LISINOPRIL, VICODIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5450981-2
Erbitux side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2007. Male patient, 48 years of age, weighting 118.0 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, fatigue, gastrointestinal disorder, pain . Erbitux dosage: 250MG/M2, IV, WKLY. During the same period patient was treated with FENTANYL, ZOLPIDEM TARTRATE, PHENYTOIN, ESOMPRAZOLE, LABETOL, AMLODIPINE, LISINOPRIL, VICODIN. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #6085500-3
Erbitux side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2009. Male patient, weighting 160.9 lb, was treated with Erbitux. After drug was administered, patient experienced the following side effects: dysphagia, exfoliative rash, fatigue, lymphopenia, oral pain, radiation skin injury, stomatitis. Erbitux dosage: unknown. Patient was hospitalized. Patient recovered.